Scientific Program

  • In November
  • Wednesday, September 23
  • Thursday, September 24
  • Friday, September 25
  • Oral Presentation

In November

[SY1B]
Hospital transfusion management

Safe and appropriate use of blood products is very important in a blood transfusion. According to the addition of the paragraph regarding the establishment and operation of the hospital transfusion committee and the blood transfusion management office in hospitals to the Korean blood management act, these mandatories will be implemented from December 2020, and hospitals that perform blood transfusions need to be prepared. The goal of the session is to help hospitals to prepare countermeasures.

Date & Time TBD Channel TBD Language Kor
Speaker(s)
  1. How to implement blood transfusion management office?
    Sinyoung Kim, Yonsei University College of Medicine, Korea
  2. Transfusion committee and patient blood management
    Tae Hyun Um, Inje University Ilsan Paik Hospital, Korea
  3. The roles of transfusion specialist in blood management
    Hyung Hoi Kim, Pusan National University School of Medicine, Korea
  4. Managing hospital transfusion committees in small to midsize hospitals
    Seon Joo Kang, DAVOS Hospital, Korea

[SY1C]
Policy trends in laboratory medicine

In this session, current policy issues related to laboratory medicines, will be introduced and discussed. Those issues are approval of national reference laboratory for infectious diseases, the third revision of relative value score, and exemption of informed consent in collecting residual samples for research.

Date & Time TBD Channel TBD Language Kor
Speaker(s)
  1. Accreditation system for national reference laboratories for infectious diseases
    Jae-Sun Park, Korea Centers for Disease Control and Prevention, Korea
  2. 3rd reorganization of the resource-based relative value scale (RBRVS)
    Woochang Lee, University of Ulsan College of Medicine, Korea
  3. Exemption of informed consent in collecting residual samples for research
    Sang Hoon Song, Seoul National University College of Medicine, Korea

[SY2A]
Improving laboratory productivity through IT system

Clinical laboratory continues to improve in productivity with the development of technology. One of the most important factor in laboratory productivity is IT system. Laboratory can handle large amounts of data and information quickly and easily with advanced it system. We're not IT professionals, so the IT still sounds like a distant talk, and it feels like a difficult area to accomplish. With this session, we would like to share experiences and explore the new technology.

Date & Time TBD Channel TBD Language Kor
Speaker(s)
  1. Laboratory Information System (LIS): Introduction and experience
    Jae Hoon Choi, EONE Laboratories, Korea
  2. The case of new IT technologies in laboratory medicine
    Soohyun Kim, Seegene Medical Foundation, Korea
  3. Making artificial intelligence real in laboratory medicine
    HackJin Lee, DoAI Inc., Korea
  4. Experience of AI system development in laboratory medicine
    Eun-Hae Cho, GC Genome, Korea

[SY3B]
Convergent evolution of specialists in the mid-sized hospitals

This session is designed to provide specialists and residents with a good foundation knowledge in all aspects of specialist's role in the mid-sized hospitals to improve abilities to solve real-world problems.

Date & Time TBD Channel TBD Language Kor
Speaker(s)
  1. Proper antibiotics usage in middle sized hospital
    Youn Jeong Kim, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Korea
  2. Subclinical iron deficiency in non-anemic korean health examinees
    Eun-Hee Nah, Korea Association of Health Promotion, Korea
  3. Chief information officer (CIO) role of laboratory medicine specialist in small and medium-sized hospital
    Yung Zoon Jung, Nasaret International Hospital, Korea
  4. Desirable functionalities of laboratory information system in the mid-sized hospitals
    Hyun-Ki Kim, University of Ulsan College of Medicine, Korea

[SY7C]
MFDS-KSLM Session
Cooperation of ministry of food and drug safety and Korean society for laboratory medicine for overcoming COVID-19

COVID-19 has caused many cases and deaths in globally. It showed the great value of diagnostic tests for quarantine. We will discuss the emergency use authorization (EUA) and usual approval process of the Ministry of Food and Drug Safety (MFDS) and approval cases of other countries for exporting Korean IVD manufacturer. Also, explain the clinical evaluation procedure and the institute of clinical performance test in accordance with act and regulations for IVD.

Date & Time TBD Channel TBD Language Kor
Speaker(s)
  1. Major subjects of IVD regulations and designation for the institute of clinical performance test
    Seung Yong Lee, Ministry of Food and Drug Safety, Korea
  2. Process of emergency use authorization (EUA) in Korea and other countries
    Kyoung Ho Roh, National Health Insurance Service Ilsan Hospital, Korea
  3. Experience of COVID-19 IVD approval for each country
    Jingu Gang, Seegene co., Korea
  4. Regulation and design of clinical performance for IVD approval
    Young-Wook Ahn, National Institute of Food and Drug Safety Evaluation, Korea

[SY8B]
Clinically unmet needs in laboratory hematology

Diagnostics of hematologic malignancies have recently been experiencing extensive modification due to the incorporation of advanced diagnostic tools into existing workflows. In this session, we will define the role of hematopathologists in the new diagnostic era by discussing the emerging diagnostic issues in the field of hematologic malignancies.

Date & Time TBD Channel TBD Language Eng
Speaker(s)
  1. Next-generation sequencing and next-generation flowcytometry in diagnostics of plasma cell disorder: Is it more useful and informative for treatment in real-world clinical settings?
    Hyun-Young Kim, Sungkyunkwan University School of Medicine, Korea
  2. Diagnostics of myelodysplastic syndrome: Can the genetics open the door to perfect diagnosis?
    Young-Uk Cho, University of Ulsan College of Medicine, Korea
  3. Germline variant screening in myeloid neoplasms: Should it be routinely tested in all patients?
    Ji-Hye Ha, Hanyang University College of Medicine, Korea

[SY9A]
Laboratory investigation of hormone and vitamins

In this session, we will discuss the clinical application of hormone tests used to diagnose and manage endocrine diseases and the recent update of the test methods. We will also look at diagnostic tests that can be used for differential diagnosis of vitamin B12 and folic acid deficiency.

Date & Time TBD Channel TBD Language Eng
Speaker(s)
  1. Vitamin B12 and folate deficiency and its laboratory investigation; Comparison of diagnostic accuracy of active B12 and total vitamin B12.
    Barnali Das, Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute, India
  2. Laboratory assessment in the diagnosis and management of parathyroid disease
    Soo Young Moon, Pusan National University School of Medicine, Korea
  3. Urine free cortisol in the diagnosis of cushing’s syndrome
    Jooyoung Cho, Yonsei University Wonju College of Medicine, Korea

[SY9B]
PHEIC (Public Health Emergency of International Concern) & EUA (Emergency Use Authorization)

WHO declared the COVID-19 outbreak to be a Public Health Emergency of International Concern (PHEIC) on January 30, 2020.
PHEIC is a formal declaration by the WHO of "an extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response".
In this session PHEIC and EUA (Emergency Use Authorization) in response to the Korea’s coronavirus outbreak will be discussed.

Date & Time TBD Channel TBD Language Eng
Speaker(s)
  1. PHEIC (Public Health Emergency of International Concern)
    Jeong Su Park, Seoul National University College of Medicine, Korea
  2. SARS-CoV-2 and COVID-19 in Korea
    Heungsup Sung, University of Ulsan College of Medicine, Korea
  3. EUA (Emergency Use Authorization) in Korea’s coronavirus outbreak
    Hyukmin Lee, Yonsei University College of Medicine, Korea

[SY10B]
Practical aspects of laboratory management (Ⅷ); Clinical laboratory environment and safety

The “Laboratory Management Committee’ will introduce the ‘Clinical Laboratory Environment and Safety’, which are the basic elements for Systematic Laboratory Management.

Date & Time TBD Channel TBD Language Eng
Speaker(s)
  1. Management of reagent water and clinical laboratory waste
    Younhee Park, Yonsei University College of Medicine, Korea
  2. Management of hazardous chemicals
    Kyoung Ho Roh, National Health Insurance Service Ilsan Hospital, Korea
  3. Clinical laboratory safety in COVID-19 test
    Chang-Ki Kim, Seoul Clinical Laboratories (SCL), Korea